Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q2 2026 · 10-Q
Revenue$17.78M$17.78M+10.6% vs Q2 2025 Net Income-$1.17M-$1.17MN/M vs Q2 2025 EPS, diluted—
Gross Profit$3,243,000+29.6% Operating Income-$1,061,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,080,000+12.8% Free Cash Flowderived$1,463,000−12.9% Margins · derivedGross margin18.2%+2.7 pt vs Q2 2025
Operating margin-6.0%+2.4 pt vs Q2 2025
Net margin-6.6%+2.7 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end